The content on this site is intended for healthcare professionals only
Dr Criscitiello speaks at EONS 10, presenting results from clinical trials of CDK4/6 inhibitors palbociclib, ribociclib and abemaciclib.
CDKs were also discussed at an ecancer symposium at ESMO 2016.
Supported by a grant from Pfizer Inc.